A detailed history of Pacer Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 47,677 shares of MRNA stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
47,677
Previous 45,298 5.25%
Holding current value
$1.76 Million
Previous $5.38 Million 40.77%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $151,399 - $297,708
2,379 Added 5.25%
47,677 $3.19 Million
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $397,755 - $654,777
3,930 Added 9.5%
45,298 $5.38 Million
Q1 2024

May 10, 2024

SELL
$85.37 - $115.44 $343,528 - $464,530
-4,024 Reduced 8.86%
41,368 $4.41 Million
Q4 2023

Jan 16, 2024

SELL
$69.51 - $104.43 $552,674 - $830,322
-7,951 Reduced 14.91%
45,392 $4.51 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $2.65 Million - $3.49 Million
-27,538 Reduced 34.05%
53,343 $5.51 Million
Q2 2023

Jul 12, 2023

SELL
$118.5 - $160.53 $2.19 Million - $2.96 Million
-18,448 Reduced 18.57%
80,881 $9.83 Million
Q1 2023

May 02, 2023

SELL
$135.66 - $197.02 $153 Million - $222 Million
-1,126,738 Reduced 91.9%
99,329 $15.3 Million
Q4 2022

Feb 06, 2023

BUY
$118.38 - $210.04 $6.75 Million - $12 Million
57,020 Added 4.88%
1,226,067 $220 Million
Q3 2022

Oct 18, 2022

BUY
$118.07 - $194.18 $17.7 Million - $29.1 Million
149,879 Added 14.71%
1,169,047 $138 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $51.3 Million - $77.4 Million
438,198 Added 75.43%
1,019,168 $146 Million
Q1 2022

Apr 05, 2022

BUY
$126.46 - $235.05 $58.9 Million - $109 Million
465,401 Added 402.7%
580,970 $100 Million
Q4 2021

Feb 03, 2022

BUY
$225.82 - $368.51 $18.9 Million - $30.8 Million
83,543 Added 260.86%
115,569 $29.4 Million
Q3 2021

Oct 15, 2021

SELL
$221.9 - $484.47 $9.66 Million - $21.1 Million
-43,512 Reduced 57.6%
32,026 $12.3 Million
Q2 2021

Jul 21, 2021

BUY
$129.91 - $234.98 $7.94 Million - $14.4 Million
61,087 Added 422.72%
75,538 $17.8 Million
Q1 2021

Apr 05, 2021

SELL
$109.18 - $185.98 $116,167 - $197,882
-1,064 Reduced 6.86%
14,451 $1.89 Million
Q4 2020

Jan 20, 2021

SELL
$65.74 - $169.86 $919,373 - $2.38 Million
-13,985 Reduced 47.41%
15,515 $1.62 Million
Q3 2020

Oct 19, 2020

BUY
$54.34 - $94.85 $1.59 Million - $2.77 Million
29,190 Added 9416.13%
29,500 $2.09 Million
Q2 2020

Jul 29, 2020

BUY
$29.67 - $80.0 $9,197 - $24,800
310 New
310 $20,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.